Atlas Trials

Serum Endostatin Type 2 Diabetic Patients

Clinical trial NCT03404037 · COMPLETED

Trial details

NCT number
NCT03404037
Sponsor
Zagazig University
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2Coronary Artery DiseaseCoronary Arteriosclerosis
Start date
2017-03-02
Primary completion
2017-11-11
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.